These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 14713385

  • 1. The perennial problem with potassium.
    Trull AK, Jackson C, Walsh S, Thornton A, Culank LS, McHugh J.
    Ann Clin Biochem; 2004 Jan; 41(Pt 1):47-52. PubMed ID: 14713385
    [Abstract] [Full Text] [Related]

  • 2. Spurious hyperkalaemia due to EDTA contamination: common and not always easy to identify.
    Cornes MP, Ford C, Gama R.
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):601-3. PubMed ID: 18768536
    [Abstract] [Full Text] [Related]

  • 3. Seasonal pseudohyperkalaemia: no longer an issue?
    Turner HE, Peake RW, Allison JJ.
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):94-6. PubMed ID: 22067093
    [Abstract] [Full Text] [Related]

  • 4. Seasonal factitious increase in serum potassium: still a problem and should be recognised.
    Davis KR, Crook MA.
    Clin Biochem; 2014 Dec; 47(18):283-6. PubMed ID: 25192691
    [Abstract] [Full Text] [Related]

  • 5. Is suboptimal phlebotomy technique impacting on potassium results for primary care?
    Bailey IR, Thurlow VR.
    Ann Clin Biochem; 2008 May; 45(Pt 3):266-9. PubMed ID: 18482914
    [Abstract] [Full Text] [Related]

  • 6. Multi-centre observational study of spurious hyperkalaemia due to EDTA contamination.
    Cornes MP, Davidson F, Darwin L, Gay C, Redpath M, Waldron JL, Ford C, Gama R.
    Clin Lab; 2010 May; 56(11-12):597-9. PubMed ID: 21141447
    [Abstract] [Full Text] [Related]

  • 7. Establishing a practical blood platelet threshold to avoid reporting spurious potassium results due to thrombocytosis.
    Thurlow V, Ozevlat H, Jones SA, Bailey IR.
    Ann Clin Biochem; 2005 May; 42(Pt 3):196-9. PubMed ID: 15949154
    [Abstract] [Full Text] [Related]

  • 8. Limitations in the use of potassium dichromate as a blood preservative for the analysis of organohalogenated compounds: two month results.
    Schecter A, Colacino JA, Shah N, Harris TR, Papke O.
    Chemosphere; 2009 Jan; 74(3):448-52. PubMed ID: 18990421
    [Abstract] [Full Text] [Related]

  • 9. The impact of centrifugation in primary care on pseudohyperkalaemia: a retrospective evaluation.
    Turner HE, Peake RW, Allison JJ.
    Ann Clin Biochem; 2013 Jul; 50(Pt 4):371-3. PubMed ID: 23761382
    [Abstract] [Full Text] [Related]

  • 10. The use of potassium dichromate and ethyl alcohol as blood preservatives for analysis of organochlorine contaminants.
    Schecter A, Pavuk M, Päpke O, Malisch R.
    Chemosphere; 2004 Oct; 57(1):1-7. PubMed ID: 15288193
    [Abstract] [Full Text] [Related]

  • 11. The phenomenon of seasonal pseudohypokalemia: effects of ambient temperature, plasma glucose and role for sodium-potassium-exchanging-ATPase.
    Sodi R, Davison AS, Holmes E, Hine TJ, Roberts NB.
    Clin Biochem; 2009 Jun; 42(9):813-8. PubMed ID: 19232334
    [Abstract] [Full Text] [Related]

  • 12. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 13. Pseudohyperkalaemia caused by recentrifugation of blood samples after storage in gel separator tubes.
    Hira K, Ohtani Y, Rahman M, Noguchi Y, Shimbo T, Fukui T.
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):386-90. PubMed ID: 11471881
    [Abstract] [Full Text] [Related]

  • 14. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA, McClure DL, Chan KA, Simon SR, Feldstein AC, Lafata JE, Andrade SE, Gunter MJ, Nelson WW, Roblin D, Platt R.
    Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
    [Abstract] [Full Text] [Related]

  • 15. Mild hypothermia, blood loss and complications in elective spinal surgery.
    Guest JD, Vanni S, Silbert L.
    Spine J; 2004 Feb; 4(2):130-7. PubMed ID: 15016389
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Mudge DW, Bofinger A, Petrie JJ, Johnson DW.
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [Abstract] [Full Text] [Related]

  • 17. Seasonal pseudohyperkalaemia.
    Sinclair D, Briston P, Young R, Pepin N.
    J Clin Pathol; 2003 May; 56(5):385-8. PubMed ID: 12719461
    [Abstract] [Full Text] [Related]

  • 18. Sample handling substantially affects Johne's ELISA.
    Alinovi CA, Ward MP, Lin TL, Wu CC.
    Prev Vet Med; 2009 Aug 01; 90(3-4):278-83. PubMed ID: 19477542
    [Abstract] [Full Text] [Related]

  • 19. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 01; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 20. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 01; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.